ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1894

Use of Facebook and Electronic Patient Portal to Identify Axial Spondyloarthritis in Patients with Chronic Back Pain

Yuliya Afinogenova1, Swetha Alexander2, Andrew Haims3 and Abhijeet Danve4, 1Yale University, Orange, CT, 2University of Connecticut, New Haven, 3Yale University, New Haven, CT, 4Yale University, Rocky Hill, CT

Meeting: ACR Convergence 2020

Keywords: Ankylosing spondylitis (AS), Back pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: Axial SpA

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Delay in diagnosis of Axial Spondyloarthritis (axSpA) remains a significant unmet need and can be partially attributed to lack of timely rheumatology referral. Current referral strategies advocate formal patient referral by non-rheumatologists, and this may be difficult given busy primary care practices and lack of awareness among non-rheumatologists of axSpA. In the ongoing Finding Axial Spondyloarthritis Study (FaxSpA), we are reaching out directly to patients by distributing online screening tool (A-tool) that we developed via electronic patient portal and Facebook. With increasing use of social media and patient participation in electronic medical record (EMR), we believe this may be a feasible approach for screening.

Methods: FaxSpA is a prospective study to evaluate the effectiveness of A-tool in identification of axSpA. A-tool contains 3 item prescreen followed by a clinical questionnaire that includes high yield axSpA features with good sensitivity and specificity. A-tool is distributed via Facebook to individuals in our geographic area and via MyChart to patients ages 18 to 65 with chronic back pain in EMR problem list. MyChart is the patient communication portal in EPIC EMR. Patients fulfilling pre-specified criteria on A-tool are contacted over the phone to confirm eligibility and then invited for clinical evaluation, labs (CRP, HLA B27) and imaging (x-ray and MRI of SI joints). Patients with diagnosed axSpA, spine surgery and age > 65 are excluded. We also collect and store blood samples for future translational biomarker research. SPSS v25 software was used for descriptive statistics and independent t-tests.  

Results: Between 4/2019 and 4/2020, 634 subjects completed the survey. Average age (44.3±13.4) was not different for MyChart vs. Facebook groups. Persistent back pain for more than 3 months was reported by 593 (94%); 495 (78%) had gradual onset back pain and 547 (86%) had back pain that started before age 45. Of 634 subjects, 428 passed pre-screen (62% vs. 74% in MyChart vs. Facebook, p=0.002). A-tool was positive in 268 (40% vs. 45% in MyChart vs. Facebook, p=0.20). Out of 268 subjects, an attempt was made to reach 256 by phone and email to confirm their eligibility and schedule a research visit. We were unable to reach 90 subjects (35%), despite multiple attempts. Sixty seven subjects (26%) were deemed ineligible after a telephone interview (15 due to history of previous surgery, 20 due to alternative explanation for their back pain, 18 due to no longer meeting criteria for pre-screen or A-tool, 14 for other reason). Another 38 subjects (15%) were either unable to come or no longer interested in the study when contacted over the phone. So far, 50 patients have been seen in the study.

Conclusion: Using electronic patient portal and social media is a feasible and efficient strategy to screen for patients with suspected axSpA. The gap between the number of patients found eligible on A-tool and those who actually came for a visit may convey that there is need to improve awareness and education about axSpA among patients. It will be interesting to evaluate the effectiveness of A-tool based referral strategy in identifying axSpA.


Disclosure: Y. Afinogenova, None; S. Alexander, None; A. Haims, pfizer, 9; A. Danve, Novartis, 1, 2, Abbvie, 5, Medscape, 5, Peerview, 8.

To cite this abstract in AMA style:

Afinogenova Y, Alexander S, Haims A, Danve A. Use of Facebook and Electronic Patient Portal to Identify Axial Spondyloarthritis in Patients with Chronic Back Pain [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/use-of-facebook-and-electronic-patient-portal-to-identify-axial-spondyloarthritis-in-patients-with-chronic-back-pain/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-facebook-and-electronic-patient-portal-to-identify-axial-spondyloarthritis-in-patients-with-chronic-back-pain/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology